BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31926642)

  • 1. Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention.
    Mangiacapra F; Bressi E; Di Gioia G; Pellicano M; Di Serafino L; Peace AJ; Bartunek J; Morisco C; Wijns W; De Bruyne B; Barbato E
    Int J Cardiol; 2020 May; 306():42-46. PubMed ID: 31926642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Coronary Microvascular Function Measured Immediately After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: An International Multicenter Study.
    Nishi T; Murai T; Ciccarelli G; Shah SV; Kobayashi Y; Derimay F; Waseda K; Moonen A; Hoshino M; Hirohata A; Yong ASC; Ng MKC; Amano T; Barbato E; Kakuta T; Fearon WF
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e007889. PubMed ID: 31525096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Danhong Injection () on Peri-Procedural Myocardial Injury and Microcirculatory Resistance in Patients with Unstable Angina Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study.
    Xing WL; Wu YJ; Liu HX; Liu QR; Zhou Q; Li AY; Zhang ZH; Li X
    Chin J Integr Med; 2021 Nov; 27(11):846-853. PubMed ID: 34263442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The index of microvascular resistance identifies patients with periprocedural myocardial infarction in elective percutaneous coronary intervention.
    Layland JJ; Whitbourn RJ; Burns AT; Somaratne J; Leitl G; Macisaac AI; Wilson A
    Heart; 2012 Oct; 98(20):1492-7. PubMed ID: 22895644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data.
    Silvain J; Zeitouni M; Paradies V; Zheng HL; Ndrepepa G; Cavallini C; Feldman DN; Sharma SK; Mehilli J; Gili S; Barbato E; Tarantini G; Ooi SY; von Birgelen C; Jaffe AS; Thygesen K; Montalescot G; Bulluck H; Hausenloy DJ
    Eur Heart J; 2021 Jan; 42(4):323-334. PubMed ID: 33257958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention.
    Ng MK; Yong AS; Ho M; Shah MG; Chawantanpipat C; O'Connell R; Keech A; Kritharides L; Fearon WF
    Circ Cardiovasc Interv; 2012 Aug; 5(4):515-22. PubMed ID: 22874078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The resting status of the coronary microcirculation is a predictor of microcirculatory function following elective PCI for stable angina.
    Layland J; Judkins C; Palmer S; Whitbourn R; Wilson-O'Brien A; MacIsaac A; Wilson A
    Int J Cardiol; 2013 Oct; 169(2):121-5. PubMed ID: 24095159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary EnalaPrilat to Reduce MICROvascular Damage During Percutaneous Coronary Intervention (ProMicro) study.
    Mangiacapra F; Peace AJ; Di Serafino L; Pyxaras SA; Bartunek J; Wyffels E; Heyndrickx GR; Wijns W; De Bruyne B; Barbato E
    J Am Coll Cardiol; 2013 Feb; 61(6):615-21. PubMed ID: 23290547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of elective percutaneous coronary intervention on microvascular resistance: a serial assessment using the index of microcirculatory resistance.
    Murai T; Lee T; Kanaji Y; Matsuda J; Usui E; Araki M; Niida T; Hishikari K; Ichijyo S; Hamaya R; Yonetsu T; Isobe M; Kakuta T
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H520-31. PubMed ID: 27342881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
    Murai T; Kanaji Y; Yonetsu T; Lee T; Matsuda J; Usui E; Araki M; Niida T; Isobe M; Kakuta T
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):233-242. PubMed ID: 27219714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Feasibility and value of index of microcirculatory resistance in patients with acute myocardial infarction after primary percutaneous coronary intervention].
    Han JL; He LY; Cui M; Zhang YZ; Liu XB; Xu XY; Wang YP; Wang FF; Wang GS; Niu J; Zhang FC; Mi L; Guo LJ; Gao W
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(29):2261-2265. PubMed ID: 28780839
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction - from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC).
    Mair J; Jaffe A; Lindahl B; Mills N; Möckel M; Cullen L; Giannitsis E; Hammarsten O; Huber K; Krychtiuk K; Mueller C; Thygesen K
    Biomarkers; 2022 Jul; 27(5):407-417. PubMed ID: 35603440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of index of microcirculatory resistance for early prediction of periprocedural myocardial microcirculatory injury after percutaneous coronary intervention in patients with coronary heart disease].
    You W; Yang ZJ; Ye F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):894-900. PubMed ID: 31744279
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Abu Sharar H; Helfert S; Vafaie M; Pleger ST; Chorianopoulos E; Bekeredjian R; Katus HA; Giannitsis E
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):578-585. PubMed ID: 31638330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprocedural myocardial infarction and injury in elective coronary stenting.
    Zeitouni M; Silvain J; Guedeney P; Kerneis M; Yan Y; Overtchouk P; Barthelemy O; Hauguel-Moreau M; Choussat R; Helft G; Le Feuvre C; Collet JP; Montalescot G;
    Eur Heart J; 2018 Apr; 39(13):1100-1109. PubMed ID: 29365133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective percutaneous coronary intervention leads to significant changes in serum resistin, leptin, and adiponectin levels regardless of periprocedural myocardial injury: an observational study.
    Buturak A; Değirmencioğlu A; Bayrak F; Kırış T; Karakurt H; Demir AR; Sürgit Ö; Ertürk M
    Anatol J Cardiol; 2016 Dec; 16(12):940-946. PubMed ID: 27443475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of eicosapentaenoic acid on peri-procedural (type IVa) myocardial infarction following elective coronary stenting.
    Kurita A; Takashima H; Ando H; Kumagai S; Waseda K; Gosho M; Amano T
    J Cardiol; 2015 Aug; 66(2):114-9. PubMed ID: 25444760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Rationale for the Endothelin-1 Receptor Antagonism in the Prevention of Microvascular Injury in Patients with non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (ENDORA-PCI) Trial.
    Liou K; Jepson N; Buckley N; Chen V; Thomas S; Russell EA; Ooi SY
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):169-75. PubMed ID: 26814686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel.
    Mangiacapra F; Pellicano M; Di Serafino L; Bressi E; Peace AJ; Di Gioia G; Morisco C; Bartunek J; Wijns W; Bruyne B; Barbato E
    Atherosclerosis; 2018 Nov; 278():23-28. PubMed ID: 30236867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.